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Dual roles of neutrophils in metastatic colonization
are governed by the host NK cell status
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The role of neutrophils in solid tumor metastasis remains largely controversial. In preclinical
models of solid tumors, both pro-metastatic and anti-metastatic effects of neutrophils have
been reported. In this study, using mouse models of breast cancer, we demonstrate that the
metastasis-modulating effects of neutrophils are dictated by the status of host natural killer
(NK) cells. In NK cell-deficient mice, granulocyte colony-stimulating factor-expanded neu-
trophils show an inhibitory effect on the metastatic colonization of breast tumor cells in the
lung. In contrast, in NK cell-competent mice, neutrophils facilitate metastatic colonization in
the same tumor models. In an ex vivo neutrophil-NK cell-tumor cell tri-cell co-culture system,
neutrophils are shown to potentially suppress the tumoricidal activity of NK cells, while
neutrophils themselves are tumoricidal. Intriguingly, these two modulatory effects by neu-
trophils are both mediated by reactive oxygen species. Collectively, the absence or presence
of NK cells, governs the net tumor-modulatory effects of neutrophils.
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Neutropenia, a condition characterized by low counts ofhost neutrophils, is a common complication in cancerpatients receiving cytotoxic therapies such as che-
motherapy and radiotherapy1. To prevent neutropenia-related
infections, cancer patients are usually administered a hemato-
poietic growth factor-granulocyte colony-stimulating factor (G-
CSF), which stimulates the de novo generation of neutrophils
through bone marrow (BM) hematopoiesis2. However, recent
preclinical studies showed that exogenous G-CSF administration
and other pathological conditions associated with neutrophil
expansion could potentially accelerate solid tumor metastases3–6.
In cancer patients, increased neutrophil counts (neutrophilia),
and a higher neutrophil-to-lymphocyte ratio were also reported
to be associated with adverse outcomes including metastatic
relapse in multiple types of solid cancers such as breast cancer,
gastric cancer, pancreatic cancer and melanoma7–11.
Increasing evidence reveals that neutrophils exert effects on
tumors, particularly metastasis-regulating effects, at the organ
colonization step - the most rate-limiting stage of the metastatic
process4,12. At the metastatic sites, neutrophils function to repress
the resident anti-tumor immunity causing an immunosuppressive
microenvironment favoring the colonization and outgrowth of
the disseminated tumor cells (DTCs)6,13. In addition to this
immunosuppressive capacity, neutrophils have also been shown
to facilitate the DTC extravasation, secrete tumor-trophic factors
and awaken the dormant DTCs via formation of neutrophil
extracellular traps (NETs)4,13,14. Together with other organ
resident cells, neutrophils nourish the pre-metastatic and meta-
static niche formation15.
Studies of neutrophil-mediated immunosuppression have
mostly focused on inhibition of T cell functions at the primary
tumor sites16,17. Primary tumor-associated neutrophils, also
called myeloid-derived suppressor cells (MDSCs), express high
levels of inducible nitric oxide synthase (iNOS) and arginase
which serve as the main mechanisms for T cell suppression18,19.
In the tumor microenvironment, iNOS-expressing neutrophils
generate nitric oxide (NO), and a series of NO-derived reactive
nitrogen species which induce T cell apoptosis and block T cell
activation and effector functions18,20. At the same time, tumor-
associated neutrophils also express arginase-1 that diminishes
CD3ζ expression on T cells thereby impairing T cell functions
through reduction of bioavailable L-arginine in the
microenvironment19,21. In addition to NO and arginase, pro-
duction of reactive oxygen species (ROS) by tumor-associated
neutrophils also serve as a mechanism to suppress the antigen-
specific response of CD8+ T cells22. Compared to the extensive
studies of neutrophil-mediated immunoregulation in the primary
tumor microenvironment, neutrophil modulation of organ-
resident anti-tumor immunity at metastatic sites has received
less attention and remains poorly defined16,17. Limited evidence
was obtained from mouse models of breast cancer lung metas-
tasis. In the lung metastatic niche, lung-infiltrating neutrophils
have been shown to restrain the anti-tumor CD8+ T cell response
by producing iNOS6, and were also capable of suppressing
intraluminal natural killer (NK) cells, although the underlying
mechanisms were not fully characterized13.
In contrast to the pro-tumoral effects described above, neu-
trophils also have documented anti-tumoral effects at the primary
tumor and metastatic sites in animal models23–25. In these animal
studies, the anti-tumoral abilities of neutrophils were mainly
mediated by their direct cytotoxic effect on tumor cells via
neutrophil-derived NO, hydrogen peroxide (H2O2), and the NET
structures, as well as anti-proliferative effects through the pro-
duction of inflammatory cytokines such as IL-1β24–27. In
humans, the tumoricidal activity of neutrophils has been known
for several decades28,29. It was reported that human neutrophils
isolated from healthy donors are highly toxic to tumor cells, but
that this activity was greatly reduced in neutrophils derived from
cancer patients30. In addition, the tumoricidal activity of human
neutrophils appeared to be cancer cell-specific as they were not
effective in killing nonmalignant normal cells30,31.
Therefore, accumulated data from preclinical and clinical
studies clearly demonstrate opposite roles of neutrophils in the
regulation of tumor growth and metastasis. Given the growing
interest in neutrophil targeting as an emerging cancer treatment
approach32, it is critical to determine the basis of the apparent
discrepancies about neutrophil interaction with cancer cells. In
previous studies, either pro-tumoral or anti-tumoral neutrophil
effects were overemphasized under specific in vivo or in vitro
circumstances. In this work, we sought to understand the dual
tumor-modulatory effects of neutrophils in the same animal
models and the same ex vivo culturing conditions. Furthermore,
previous studies used a wide variety of different mouse strains,
with different genetic backgrounds, for the mouse cancer
models. Thus, the genetic variation among mouse strains could
also contribute to the contradictory conclusions drawn for
neutrophil interactions with tumor cells because immune phe-
notypes vary greatly among mice with different inbred genetic
backgrounds33,34. In particular, mice with different levels of
immune system integrity, such as immunocompetent versus
immunodeficient mice, were variously utilized in cancer studies
focusing on neutrophils3,4,13,24.
Based on the above facts, in the present study we set out to test
the hypothesis that the integrity of the host immune system may
account for the discrepant roles of neutrophils in mouse cancer
models. We perform side-by-side experiments using the same
breast tumor models in both immunocompetent and immuno-
deficient mice. Our results show that neutrophils exert opposite
effects in regulation of metastatic colonization in NK cell-
competent versus NK cell-deficient mice. Ex vivo mechanistic
studies reveal that neutrophils suppress the tumoricidal activity of
NK cells, while they themselves are also tumoricidal though to a
lesser extent compared to NK cells. Thus, in the absence of NK
cells, neutrophils are metastasis-inhibitory, but they show a net
effect of metastasis promotion in the presence of NK cells. Our
results suggest that the host immune cell status is a predominant
factor for neutrophil-mediated modulation of metastasis. It is
necessary to evaluate a patient’s immune status in clinical man-
agement of G-CSF-based neutropenia treatment, as well as in
developing new neutrophil-targeting cancer therapeutics.
Results
G-CSF injection has distinct metastatic outcomes in mice.
Neutrophils play a critical role in solid cancer metastases but they
have been shown to possess both metastasis-promoting and
-suppressing capacities. Previous work suggests that neutrophils
exert these metastasis-modulating effects as DTCs colonize the
metastatic organs35. In this study, we first assessed the capability of
G-CSF-induced neutrophil expansion (Supplementary Fig. 1a–c)
to modulate metastasis using an experimental metastasis model in
which metastatic colonization can be quantified (Fig. 1a). Con-
sistent with previous studies3,13, exogenous G-CSF did augment
E0771 breast tumor cell colonization in the lung in immuno-
competent host mice (Fig. 1b). To determine whether the immune
system integrity affects the role of neutrophils in metastatic colo-
nization, we employed the same experimental metastasis model in
immunodeficient host strains including NOD-scid mice, which
lack T and B cells, and NOD-scid IL2rγnull (NSG) mice, which lack
T, B and NK cells. Unexpectedly, opposite results were obtained in
these two recipient strains (Fig. 1c, d). While G-CSF pre-treatment
showed a pro-metastatic effect in NOD-scid recipients similar to
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that in immunocompetent C57BL/6J mice (Fig. 1c), it strikingly
suppressed the metastatic colonization of E0771 cells in NSG mice
(Fig. 1d).
A major immune system difference between NOD-scid and
NSG hosts is, respectively, the presence and absence of NK cells36
(Supplementary Fig. 1d). In NOD-scid mice, NK cells retained
tumoricidal activity, though to a lesser extent than measured in
the immunocompetent C57BL/6J mice (Supplementary Fig. 1e),
which was consistent with previous studies37. To further exclude
the possibility of other cellular differences between the NOD-scid
and NSG strains besides NK cell presence, we performed NK cell
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Fig. 1 G-CSF-induced neutrophilia exerted pro-metastatic and anti-metastatic effects in NK cell-competent and NK cell-deficient mice, respectively.
a–d G-CSF administration showed distinct effects on breast tumor cell colonization in the lungs of C57BL/6J (b), NOD-scid (c), and NSG mice (d). As
depicted in a, all mice received intraperitoneal (i.p.) injection of recombinant mouse G-CSF (2.5 μg per mouse) for 6 consecutive days. On day 3, the mice
were implanted with E0771-Luc cells by intravenous (i.v.) injection. The metastatic progression of E0771-Luc cells was then monitored by bioluminescence
imaging (BLI). Quantification of photon flux and comparison of metastatic colonization in the lungs of mice are shown (b, left; c and d, top), and the
endpoint bioluminescence images of lungs are shown (b, right; c and d, bottom). n= 5 mice per group. P values were determined by two-way ANOVA
(PBS group versus G-CSF group). e–g NK cell depletion converted G-CSF-induced pro-metastatic effect to anti-metastatic. As depicted in e, all mice first
received i.p. injection of recombinant mouse G-CSF (2.5 μg per mouse) for 6 consecutive days. To deplete NK cells, NOD-scidmice (f) and B6-scidmice (g)
were i.p. injected with anti-asialo GM1 (25 μl per mouse) and anti-NK1.1 (25 μg per mouse), respectively, every 3 days starting from day 1. On day 3, the
mice were implanted with E0771-Luc cells by i.v. injection. At the endpoint, the metastatic progression of E0771-Luc cells in the lungs was detected by
ex vivo BLI. The endpoint bioluminescence images (left) and the quantification of photon flux of lungs (right) are shown. n= 5 (IgG) or 6 (anti-asialo GM1)
NOD-scid mice per group (f). n= 5 B6-scid mice per group (g). P values were determined by unpaired two-tailed t-test. Data are represented as mean ±
SEM. Source data are provided as a Source data file.
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and B6-scid mice, respectively. As shown in Fig. 1e–g and
Supplementary Fig. 1f–g, depletion of NK cells converted the G-
CSF-induced pro-metastatic effect to an anti-metastatic effect.
We therefore reasoned that the presence or absence of host NK
cells has a dominant role in determining which effect is produced
by G-CSF-expanded neutrophils in metastatic colonization. In
other words, the integrity of the host immune system is a
determinant in neutrophil-mediated metastasis regulation.
Tumor-derived G-CSF is pro- or anti-metastatic in vivo. Other
than exogenous G-CSF administration in treatment of neu-
tropenia, tumor cell-intrinsic G-CSF expression is another clinical
condition that causes elevated neutrophil counts40,41. The high
expression of G-CSF in tumor cells or tissues has been associated
with more robust metastatic potential in preclinical tumor
models3,13, and poor prognoses in patients with solid tumors42,43.
To further evaluate whether the presence or absence of NK cells is
a key factor in determining the pro- vs anti-metastatic roles of G-
CSF and neutrophils, we constructed G-csf-overexpressing
E0771 cells (E0771-g-csf). As expected, compared to the E0771
parental line, implantation of E0771-g-csf cells resulted in a
striking increase of host neutrophils but not of other myeloid
lineage cells in the lung and peripheral blood (Supplementary
Fig. 2a, b).
Next, we adopted a modified experimental metastasis model in
which E0771 and E0771-g-csf cells were first orthotopically
implanted in mice to establish non-inflammatory (neutrophillow)
and inflammatory (neutrophilhigh) tumor-bearing host condi-
tions, respectively (Supplementary Fig. 2c). At the pre-metastatic
stage in these orthotopic tumor models (Supplementary Fig. 3a),
the mice received intravenous injections of luciferase-labeled
E0771 cells (E0771-Luc) (Fig. 2a). By monitoring the E0771-Luc
cell progression in the lung by bioluminescence imaging (BLI), we
were able to compare differences between the neutrophilhigh
(E0771-g-csf) vs non-inflammatory (E0771) host conditions in
their accommodation of tumor cells. Consistent with the
exogenous G-CSF pre-treatment results, tumor cell-intrinsic G-
csf overexpression and the resulting host neutrophilia, were again
shown to be pro-metastatic in NOD-scid mice, but anti-
metastatic in NSG mice (Fig. 2b and Supplementary Fig. 4a, b).
Similar results were obtained using another genetically distinct
AT3 tumor cell line, which was originally derived from a breast
tumor arising in MMTV-PyMT transgenic mice44 (Supplemen-
tary Figs. 3b and 4c–e).
Although organ colonization is recognized as a main step for
neutrophil-mediated metastasis-regulatory effects3,4,13, neutro-
phils have also been reported to be important in other metastatic
stages such as primary tumor cell invasion and circulating tumor
cell survival45,46. To fully understand whether the systemic effect
of neutrophils in metastasis also relies on NK cells, we next
employed spontaneous metastasis models in NK cell-competent
and -deficient mice. To this end, G-csf-overexpressed E0771
tumor cells were compared with their parental cells (E0771) for
levels of spontaneous metastases in NOD-scid and NSG mice.
Intriguingly, G-csf-overexpression-induced neutrophilia did not
affect primary tumor growth, but depending on the host, either
enhanced (NOD-scid) or mitigated (NSG) the development of
spontaneous lung metastases (Fig. 2c–g). Similar results were
obtained using the AT3 tumor model (Supplementary Fig. 4f–i).
Therefore, overexpression of G-csf in tumor cells led to distinct
metastatic outcomes in NK cell-competent and –deficient host
mice in both experimental and spontaneous metastasis models.
While G-CSF mainly drives neutrophil lineage differentia-
tion, its overexpression in tumor cells also leads to a modest
change in other myeloid lineage cells in recipient mice
(Supplementary Fig. 2a, b). To further pinpoint the specific
roles of neutrophils in modulation of metastasis, we next
selectively depleted neutrophils using anti-Ly6G (clone 1A8) in
the modified experimental metastasis model (Fig. 2h). As shown
in Fig. 2i, depletion of neutrophils nearly abolished tumor cell
G-csf overexpression-induced pro- or anti-metastatic effects
in vivo. Furthermore, neutrophil depletion was applied in the
4T1 spontaneous lung metastasis model, which is known for
strong induction of neutrophilia3,13. As expected, anti-Ly6G-
mediated neutrophil depletion again showed opposite effects in
NK cell-competent and –deficient mice: an anti-metastatic
effect in NK cell-competent BALB/c mice and NOD-scid
mice, but a pro-metastatic effect in NSG mice (Fig. 2j and
Supplementary Fig. 5). Interestingly, neutrophil depletion only
influenced lung metastasis progression, but did not change
primary 4T1 tumor growth in any mouse strains we tested
(Supplementary Fig. 5b–d) suggesting neutrophils have a
regulatory role specific to metastasis.
Therefore, in both exogenous G-CSF administration and tumor
cell G-csf overexpression-induced neutrophilia conditions, neu-
trophilia had an anti-metastatic effect in host mice lacking NK
cells but a pro-metastatic effect in host mice with NK cells. These
results suggested that the host NK cell status is indeed a master
regulator of neutrophils’ functions in lung metastasis of breast
cancer.
Neutrophils suppress NK cells but are also tumoricidal. NK
cells and T cells are recognized as the major components of
organ resident immunosurveillance during organ-tropic
metastasis47. Specific for metastatic colonization, our results
suggested that NK cells played a dominant role because
NK cell-deficient NSG mice allowed a strikingly higher level of
tumor cell colonization in the lung, in comparison to NOD-
scid and immunocompetent recipients (Supplementary Fig. 6).
This result is also supported by recent work from other groups
showing NK cell depletion was more effective than T cell
depletion in restricting lung metastasis in solid cancer
models48,49. Based on these facts and our in vivo findings
as shown in Figs. 1, 2, we propose a tricellular interaction
model to explain the observed opposite metastasis-modulating
effects of neutrophils in hosts that differ in immune system
integrity: both neutrophils and NK cells are tumoricidal, but
NK cells possess a more robust cytotoxic capacity than neu-
trophils. In the absence of NK cells (NSG hosts), neutrophils
show a net tumoricidal/anti-metastatic effect while, in the
presence of NK cells (NOD-scid and immunocompetent hosts),
neutrophils suppress the more tumoricidal NK cells and
therefore have the net effect of promoting metastatic coloni-
zation (Fig. 3a).
Our first examination of the proposed three-way interactions
among neutrophils, NK and tumor cells used in vivo monitoring
of infused tumor fates during the very early stage of metastatic
colonization, a time window when NK cells and neutrophils kill
most of the invading tumor cells12,13. Consistent with the long-
term outcomes shown in Fig. 2a, b, the effects of tumor cell G-csf-
overexpression-induced neutrophilia were again host dependent:
pro-survival in NOD-scid (Fig. 3b, c) but anti-survival in NSG
mice in vivo (Fig. 3d, e), with the effects evident as early as 2–4 h
post-injection. To determine whether the opposing patterns of
tumor cell survival were due to differences in tumor cell killing
under different host conditions, we next measured the tumor-
icidal activities of neutrophils and NK cells separately and in
combination ex vivo. Based on the immunostaining of neutro-
phils, NK cells and tumor cells in lung sections from tumor-free
and tumor-bearing mice (Supplementary Fig. 7) and the cell-cell
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ratios applied in previous reports24,50, we adopted the ratios of
5–20:1 (neutrophil: tumor cells) and 10–20:1 (NK: tumor cells) to
produce the following ex vivo results.
First, lung-infiltrating neutrophils were indeed tumoricidal
and, interestingly, the tumor-killing ability of lung neutrophils
did not vary based on host origin. Killing ability was similar
whether neutrophils were isolated from NK cell-competent or NK
cell-deficient mice (Fig. 3f), or from mice with non-inflammatory
or inflammatory conditions (Fig. 3g).
Second, lung-infiltrating NK cells were far more effective than
neutrophils in killing tumor cells, but their tumoricidal ability was
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condition (Fig. 3g–i and Supplementary Fig. 8a, b). This indicated
the possibility for neutrophil-mediated suppression of NK cell
functions. Indeed, in both E0771 and AT3 models a significant
reduction of the effector IFNγ+ and CD107+ lung-infiltrating NK
cells was detected in neutrophilhigh host mice, in spite of no
change in total NK cell number (Fig. 4a–d and Supplementary
Fig. 8c–f). This lung NK cell suppression was largely reversed
when neutrophils were systemically depleted, a finding that
further emphasizes the specific role of neutrophils in modulating
the host anti-tumor immunity (Fig. 4e–h). Interestingly, NK cells
were not simultaneously affected by neutrophils at the primary
tumor sites which again suggests neutrophil-mediated immuno-
suppression is tissue specific (Supplementary Fig. 8g–i).
Third, to further clarify the triangular relationship among
neutrophils, NK cells and tumor cells, we performed a three cell
population ex vivo co-culture using lung neutrophils derived from
tumor-bearing mice and normal NK cells isolated from naïve mice.
Consistent with the results above, either neutrophils or NK cells
alone were tumoricidal although neutrophils killed tumor cells less
robustly than NK cells (Fig. 4i–k). However, a combination of both
neutrophils and NK cells did not increase the tumoricidal effect
(Fig. 4i–k) which supports the involvement of neutrophil-mediated
NK cell suppression as indicated above. Further, the tri-cellular
interaction was independent of the neutrophil source as neutro-
phils isolated from non-inflammatory and inflammatory host
mice showed comparable effects on NK cells and tumor cells
(Supplementary Fig. 8j).
Taken together, these in vivo and ex vivo results unambigu-
ously support the proposed tricellular interaction model. On the
one hand, both neutrophils and NK cells are tumoricidal, though
the latter is more effective, but on the other hand, neutrophils can
also suppress the tumorcidal activity of NK cells. Thus, under a
given host condition, tumor progression ultimately depends, not
on a single factor, but on the interactions among neutrophils, NK
cells, tumor cells and quite possibly other components in the
tissue microenvironment (Fig. 3a).
Neutrophils regulate both NK and tumor cells via ROS. In
previous studies, investigation of neutrophil-mediated immuno-
suppression was primarily focused on T cells which are repressed
by a variety of neutrophil-derived immunoregulatory factors such
as NO and ROS6,18,20,23. In contrast, fewer studies focused on NK
cells, the essential anti-tumor host immune cells in the organ
metastatic niche. Limited evidence supports the idea that organ-
infiltrating neutrophils suppress the ability of NK cells to undergo
functional activation13, but a mechanistic understanding of
neutrophil-mediated NK cell inhibition is not yet available.
We set out to determine the molecular basis by which
neutrophils suppress NK cell functions by focusing on known
immunoregulatory factors including ROS and NO, both of which are
recognized to be critical in inflammation and cancer51–53. The main
bioactive ROS molecules are produced through a series of enzyme-
catalyzed reactions: oxygen (O2)→superoxide (O2•−)→hydrogen
peroxide (H2O2)→H2O2 derivatives (such as hydroxyl radicals and
hypochlorous acid)54. Among the key enzymes catalyzing these
reactions, nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase catalyzes O2 to O2•−, whereas catalase converts H2O2 into O2
and water. NO, another type of redox molecule, can be coupled with
the ROS pathway by reacting with superoxide to produce reactive
nitrogen species such as peroxynitrite (ONOO−)54.
In the typical bicellular neutrophil-NK cell co-culture system,
selective inhibition of NADPH oxidase by histamine dihy-
drochloride (HDC) or apocynin, or stimulation of H2O2
decomposition by catalase remarkably increased the proportion
of effector IFNγ+ NK cells which were repressed by lung
neutrophils, whereas inhibition of NO was ineffective (Fig. 5a, b).
Functionally, blocking the ROS pathway, but not NO, largely
abolished lung neutrophil-mediated suppression on the tumor-
icidal activity of NK cells as determined in the tricellular co-
culture system (Fig. 5c). Therefore, the ROS pathway is revealed
as a primary mechanism by which lung neutrophils can suppress
NK cell functions.
To further delineate the association of neutrophils with the
ROS pathway in vivo, we measured endogenous lung ROS levels
in mice bearing E0771 and E0771-g-csf tumors. The ROS levels in
the lung were significantly elevated when the hosts underwent
neutrophilia driven by tumor cell G-csf overexpression. Such an
elevation was markedly abrogated by neutrophil depletion with
anti-Ly6G (Fig. 5d) indicating that the burst of ROS in the lungs
is primarily, if not exclusively, caused by neutrophils.
As ROS are bioactive species that nonspecifically target diverse
types of cells and tissues in inflammation and cancer, the greatly
heightened lung endogenous ROS levels prompted us to speculate
whether these neutrophil-derived ROS may also influence tumor
cells. Using the ex vivo neutrophil-tumor cell co-culture, we
observed reductions in neutrophil tumoricidal activity in
response to either inhibition of NADPH oxidase by apocynin
or HDC, or stimulation of H2O2 degradation of by catalase
(Fig. 5e, f). Therefore, the ROS pathway emerges as a main
mechanism which drives neutrophils to nonspecifically target
both NK cells and tumor cells at the metastatic site.
In addition to mediating cytotoxic effects from the effector to
target cells, ROS have also been reported to participate in
modulating intracellular signaling cascades in various types of
cells such as neutrophils55. To affirm ROS as key neutrophil-
Fig. 2 Tumor cell-derived G-CSF is pro-metastatic or anti-metastatic depending on the host NK cell presence. a, b Neutrophilia caused by G-csf-
overexpression in tumor cells increased metastatic colonization in NOD-scid mice, but not in NSG mice in a modified experimental metastasis model.
Following the experimental design as in a, the metastatic progression of E0771-Luc cells was monitored by BLI. Quantification of photon flux and
comparison of metastatic colonization in the lungs of mice are shown (b). n= 9 mice per group. P value was determined by two-way ANOVA. c–g As
depicted in c, NSG mice (d, e), and NOD-scid mice (f, g) were orthotopically implanted with E0771-Luc or E0771-Luc-g-csf cells. At the endpoint (day 30
for NOD-scid and day 20 for NSG mice), the spontaneous lung metastases were assessed by ex vivo BLI (d, f), and the primary tumors were also dissected
and weighed (e, g). n= 10 (d, e) or 8 (f, g) mice per group. P values were determined by unpaired two-tailed t-test. ns, not significant. h, i Neutrophil
depletion abolished the metastasis-regulating effects of tumor cell G-csf overexpression in the experimental metastasis model. A schematic diagram was
depicted in h showing the experimental design. Quantification of photon flux and comparison of metastatic colonization in the mouse lungs are shown on
the top, and the endpoint bioluminescence images of lungs are shown on the bottom (i). n= 5 mice per group. P values were determined by two-way
ANOVA. ns not significant. Ly6Gab: Anti-Ly6G antibody. j In the 4T1 spontaneous metastasis model neutrophil depletion showed anti-metastatic and pro-
metastatic effects in NK-cell competent (BALB/c and NOD-scid) and NK cell-deficient (NSG) mice, respectively. The lung metastases were examined by
ex vivo BLI and quantification of photon flux of lungs are shown. n = 9 (IgG group) and 8 (Ly6Gab group) for BALB/c mice; and n= 5 per group for NOD-
scid and NSG mice. P values were determined by unpaired two-tailed t-test. Data are represented as mean ± SEM. Source data are provided as a Source
data file.
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Fig. 3 The metastasis-modulating effects by neutrophils occur at the early stage of metastatic colonization. a Model depicting the dual roles of
neutrophils in metastatic colonization. In the absence of NK cells, neutrophils exclusively exert their tumoricidal effect thereby showing a net anti-
metastatic effect; in the presence of NK cells, neutrophils are also tumoricidal but they suppress the more tumoricidal NK cells leading to a net pro-
metastatic effect. b–e Determination of neutrophilia-induced metastasis regulation at the early stage of colonization. The diagrams in b, d show the
experimental designs in c, e, respectively. The representative BLI images (left), and quantification of photon flux (right) in each group at various time points
are shown in c, e. n= 5 NOD-scid mice in c and 6 NSG mice in e per group. P values were determined by unpaired two-tailed t-test. f Comparison of the
tumoricidal activities of neutrophils isolated from C57BL/6J, NOD-scid and NSG mice. Lung-infiltrating neutrophils were freshly isolated from E0771-g-csf
tumor-bearing mice for ex vivo cytotoxic assay against AT3 cells. Statistical significance was determined by two-way ANOVA. Neu: neutrophils. g–i The
tumoricidal capacities of neutrophils and NK cells under non-inflammatory and neutrophilhigh inflammatory conditions. E0771 cells and E0771-g-csf cells
were orthotopically implanted in NOD-scid mice to induce non-inflammatory and inflammatory tumor-bearing host conditions, respectively, with PBS
injection as a control. The mice were sacrificed at the pre-metastatic stage (day 10), and lung-infiltrating neutrophils were isolated for the ex vivo cytotoxic
assay against AT3 cells (g). Statistical significance was determined by two-way ANOVA. Lung-infiltrating NK cells were also isolated from the same mice
for the ex vivo cytotoxicity assay against AT3 (h) or YAC-1 cells (i). P values were determined by unpaired two-tailed t-test (h, i). Data are represented as
mean ± SEM (c, e) or mean ± SD of four biologically independent cell cultures (f–i). ns not significant. Source data are provided as a Source data file.
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derived extracellular mediators that act on tumor cells and NK
cells, we prepared cell-free conditioned medium (CM) from lung
neutrophils and tested whether the medium functioned similarly
to neutrophil cells towards tumor cells and NK cells. As shown in
Supplementary Fig. 9a–c, the lung neutrophil-derived CM was
indeed effective in killing tumor cells and suppressing the
tumoricidal activity of NK cells. As expected, stimulation of H2O2
decomposition by catalase, but not inhibition of the intracellular
NADPH oxidase, reversed the effects of the neutrophil CM. These
results indicated that neutrophil-derived ROS are able to exert
extracellular effects on tumor cells and NK cells although the
ROS-mediated intracellular functions in neutrophils are not
completely excluded.
ROS blockade abolishes the dual roles of neutrophils in vivo.
As evidenced by our ex vivo work described above, neutrophils
require the ROS pathway to exert both tumoricidical and NK cell
suppressive effects. We then wondered whether pharmacological
inhibition of the ROS pathway could serve as an effective
approach to manage the modulatory functions of neutrophils in
metastatic colonization. To this end, we first examined whether
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Fig. 4 Neutrophils inhibit the tumoricidal activity of NK cells. a–d Neutrophilia induced effector NK cell suppression in the pre-metastatic lungs. As
depicted in a, NOD-scid mice were orthotopically injected with E0771 or E0771-g-csf cells. The mice were sacrificed at day 10. The total numbers of lung-
infiltrating NK cells were calculated upon analysis by flow cytometry (b), and the percentages of IFNγ+ (c), and CD107a+ effector NK cells (d) were
determined by flow cytometry. n = 5 mice per group. P values were determined by unpaired two-tailed t-test. e–h Depletion of neutrophils abolished tumor
cell G-csf-overexpression-induced NK cell suppression. As depicted in (e), E0771 or E0771-g-csf cells were orthotopically implanted in NOD-scid mice, and
the mice received control IgG or anti-Ly6G (Ly6Gab) daily 2 days after tumor cell implantation. The mice were sacrificed at day 10, and the total number of
lung-infiltrating NK cells were calculated upon analysis by flow cytometry (f). The percentages of IFNγ+ (g) or CD107a+ effector NK cells (h) were
determined by flow cytometry. n = 5 mice per group. P values were determined by one-way ANOVA with Tukey’s multiple comparisons test. i–k In i, a
schematic diagram is to show the experimental design in j, k. Neutrophils were freshly isolated from the lungs of E0771-g-csf orthotopic tumor-bearing
NOD-scid mice, and NK cells were derived from spleens of naïve NOD-scid mice. An ex vivo cytotoxicity assay was performed in a co-culture system
including neutrophils, NK cells and tumor cells (3 × 104 AT3 cells or 1 × 104 YAC-1 cells), with the ratios of neutrophil: NK cell: tumor cells at 10:10:1 or
20:20:1. The percentages of AT3 cells (j) and YAC-1 cells (k) killed by neutrophils and NK cells individually or together were determined. P value was
determined by one-way ANOVA with Tukey’s multiple comparisons test. Data are represented as mean ± SEM (b–d, f–h) or mean ± SD of four biologically
independent cell cultures (j, k). ns not significant. Source data are provided as a Source data file.
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ROS levels in the lung in vivo. Indeed, treatment with the
NADPH oxidase inhibitor HDC significantly decreased the lung
ROS levels in mice with neutrophilia induced by tumor cell G-csf
overexpression (Fig. 6a, b). In accordance with the reduced ROS
levels, neutrophilia-induced effector NK cell suppression was
largely alleviated by HDC treatment, while the total number of
lung-infiltrating NK cells remained unchanged (Fig. 6c–e).
We further adopted the modified experimental metastasis
model, as outlined in Fig. 2a, to evaluate how blocking
neutrophil-derived ROS would ultimately alter the progression
of metastasis in NK cell-competent and –deficient recipient mice.
The HDC treatment was started at the pre-metastatic stage, when
the ROS burst had already emerged (Fig. 6b), and went on into
the metastatic stage (Fig. 6f–i). Similar to the effects caused by
neutrophil depletion (Fig. 2h–i), ROS inhibition profoundly
abrogated the neutrophilia-induced pro-metastatic effect in NK
cell-competent NOD-scid mice (Fig. 6f, g), and anti-metastatic
effect in NK cell-deficient NSG mice (Fig. 6h, i). Thus, these
findings indicate that the ROS pathway is essential in dictating
the dual roles played by neutrophils in metastatic colonization.
Discussion
Using mice with different levels of immune system integrity, our
in vivo data suggested that G-CSF-expanded neutrophils were
anti-metastatic in NK cell-deficient mice, but pro-metastatic in
NK cell-competent mice. Further mechanistic studies indicated
an interactive relationship among neutrophils, NK cells and
tumor cells. Specifically, NK cells are more tumoricidal than
neutrophils, and neutrophils exert inhibitory effects on NK cells
and cytotoxic effects on tumor cells. Therefore, in the absence of
NK cells, neutrophils only showed their tumoricidal ability or a
net anti-metastasis effect, while in the presence of NK cells,
although neutrophils were still tumoricidal they suppressed the
more tumoricidal NK cells resulting in a net pro-metastatic effect
(Fig. 3a). Finally, the ROS pathway was revealed to be necessary
for neutrophils to exert the dual roles. Taken together our results
show that the host immune status, especially the NK cell state,
dictates the net contribution of neutrophils to metastasis. Our
findings therefore offer a model that provides a coherent inter-
pretation of controversial findings surrounding the role of neu-
trophils in metastatic colonization.
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Fig. 5 The tumoricidal and NK-suppressive effects of neutrophils are both mediated by ROS. a–c Neutrophils suppress NK cell functions via ROS. As
depicted in a, in the co-culture system including neutrophils and NK cells, apocynin, histamine dihydrochloride (HDC), catalase or 1400W was added at
the beginning of the co-culture, and the cells were then primed with PMA and ionomycin for 4 hours before determination of IFNγ+ NK cells by flow
cytometry (b) or for the ex vivo cytotoxicity assay against AT3 cells (c). Neutrophils were freshly isolated from the lungs of E0771-g-csf orthotopic tumor-
bearing NOD-scid mice, and NK cells were derived from spleens of naïve NOD-scid mice. d Depletion of neutrophils reduced the elevated lung ROS levels
caused by tumor cell G-csf overexpression. NOD-scid mice received control IgG or anti-Ly6G antibody (Ly6Gab) daily 2 days after E0771 or E0771-g-csf
orthotopic implantation, for 10 consecutive days. Then the mouse lungs were isolated for determination of the ROS levels by bioluminescence (probe L-
012). The ROS levels were normalized to the average of the values from the E0771 implanted group treated with IgG. n= 4 (IgG group) and 5 (Ly6Gab
group) mice per group. e, f The tumoricidal effect of neutrophils was dependent on ROS. Lung-infiltrating neutrophils were freshly isolated from E0771-g-csf
orthotopic tumor-bearing NOD-scid mice (e) or NSG mice (f) for measuring of their cytotoxic effect on AT3 cells (3 × 104 AT3 cells) at the effector: target
ratio of 20: 1. Apocynin, HDC or catalase was added at the beginning of culture. Data are represented as mean ± SD of four biologically independent cell
cultures (b, c, e, f) or mean ± SEM (d). P values were determined by one-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Source
data are provided as a Source data file.
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Our work also has clinical implications. G-CSF has been widely
used in cancer patients who receive cytotoxic therapies and
consequently develop neutropenia2. The main function of G-CSF
is to stimulate the de novo generation of neutrophils through
hematopoiesis, although this cytokine has also been suggested to
influence other myeloid lineage cell development56 and to directly
act on NK cells57. As shown in Supplementary Figs. 1a–c and 2a,
b, both exogenous G-CSF administration and G-csf over-
expression in tumor cells caused a remarkable expansion of
neutrophils, with only minimal or insignificant changes in other
myeloid lineage cells and adaptive immune cells in host mice.
Furthermore, the direct effect of G-CSF on NK cells was also
examined. In this case, exogenous addition of recombinant G-
CSF did not change the proportion of effector NK cells or their
tumoricidal ability (Supplementary Fig. 10a–c). These data
highlighted the specificity of G-CSF in driving host neutrophilia
and subsequently regulating metastasis.
The results in Fig. 1 indicated that exogenous G-CSF adminis-
tration enhanced tumor cell metastatic colonization in host mice
with intact NK cells, but an opposite anti-metastatic effect in host
mice lacking functional NK cells. Cancer patients with cytotoxic
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Fig. 6 Inhibition of ROS pathway abrogates the pro-metastatic and anti-metastatic effects of neutrophils in vivo. a–e ROS blockade reversed
neutrophilia-induced NK cell suppression. As depicted in a, ROS inhibitor HDC or the vehicle control was given to the NOD-scid mice bearing E0771 or
E0771-g-csf orthotopic tumors at the pre-metastatic stage (day 8 and 10). On day 11, the mouse lungs were isolated for ROS level determination by
bioluminescence (probe L-012) (b), total lung-infiltrating NK cell counting (c), and measurement of IFNγ+ NK cells (d) and CD107a+ NK cells (e) by flow
cytometry. n= 5 mice per group. f–i Administration of the ROS inhibitor HDC abolished the tumor cell G-csf overexpression-induced metastases-regulatory
effects. As depicted in f, h, NOD-scid (g) or NSG (i) mice were first orthotopically injected with unlabeled E0771 and E0771-g-csf cells to generate the non-
inflammatory and inflammatory host conditions, respectively. E0771-Luc cells were i.v. infused at the pre-metastatic stage (day 10). From day 8, the mice
also received HDC (1mg per mouse) every other day. At the endpoint, the metastatic progression of E0771-Luc cells in the lungs was detected by ex vivo
BLI. The bioluminescence images (left) and the quantification of photon flux of lungs (right) are shown (g, i). n= 6 mice per group. Data are represented as
mean ± SEM. P values were determined by one-way ANOVA with Tukey’s multiple comparisons test. ns, not significant. Source data are provided as a
Source data file.
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collapse of other immune cell populations, including NK cells,
which are also susceptible to cytotoxic drugs58. Thus, to some
extent, these patients resemble NSG mice with their severe immune
defects. As such, it is anticipated that exogenous G-CSF adminis-
tration may lead to a net anti-metastatic outcome in neutropenia
patients. Indeed, clinical data reveal that G-CSF treatment was
mostly safe and significantly reduced the risk of infection-related
mortality and early mortality from all causes in neutropenia
patients2. Based on our results in mice, patients with high levels of
immune defects, such as those with risk of febrile neutropenia59,
may gain more benefit from the G-CSF treatment. In contrast,
individuals retaining a relatively intact immune system, particularly
functional NK cells, could risk metastatic relapse in response to
exogenous G-CSF treatment.
An increase in the neutrophil-to-lymphocyte ratio has been
repeatedly reported to be correlated with poor prognoses
including distant metastases in various types of solid cancers8,9.
According to our data, in hosts with neutrophilia the immuno-
suppressive effect of neutrophils may prevail over their tumor-
icidal activity and lead to a net pro-tumoral effect. This could
happen at the early stages of cancer progression when the host
immune system was still in a relatively intact state. In the last
decade, strategies targeting hematopoietic growth factors and
neutrophil trafficking have been explored in clinical trials to treat
advanced solid cancers60,61. Our results would suggest that future
clinical application would benefit from careful evaluation of each
individuals’ immune status prior to neutrophil-targeting therapy.
In patients with defective NK cells caused by cytotoxic ther-
apeutics or other pathological conditions, the G-CSF- or
neutrophil-targeting therapy may abrogate the neutrophils’
tumoricidal ability leading to deleterious outcomes. Hence, a
personalized immune status assessment should be considered for
both clinical use of G-CSF in neutropenia treatment, and as a
design component of new neutrophil-targeting approaches to
treat solid cancer metastasis.
In addition to the important clinical implications described
above, our results also shed light on the ongoing need for optimal
selection of preclinical animal models. Our work clearly shows
that opposite conclusions could be obtained with regard to the
functional contribution of neutrophils in lung metastasis
depending on whether data were derived from NOD-scid or NSG
mice. Therefore researchers need to be cautious when using these
mice, or others that differ in immune system integrity, to study
the functions of immune cells in cancer. Owing to the close
interactions among different populations of immune cells in the
tumor microenvironment, the function of one type of immune
cell could be altered by the loss of another type of immune cells62.
For example, in mouse models of fibrosarcoma and lung carci-
noma, depletion of NK cells strengthened the tumor-promoting
effect of primary tumor-associated neutrophils via the increased
expression of angiogenetic factors in neutrophils63. In our study,
we also conducted a comprehensive comparison of lung-
infiltrating neutrophils isolated from NK cell-competent
(C57BL/6J and NOD-scid) and NK cell-deficient mice (NSG). It
was shown that lung-infiltrating neutrophils did not significantly
differ in host NK cell status, either phenotypically or functionally,
including their tumoricidal effect (Fig. 3f), NK cell suppressive
effect (Supplementary Fig. 11a), ROS producing levels (Supple-
mentary Fig. 11b) and expression of the key genes relevant to
neutrophil biology in cancer (Supplementary Fig. 11c).
Besides differences in immune system integrity, additional
immune system variations related to genetic background also
need to be considered in murine cancer models. The mouse strain
differences in T cell- and NK cell-mediated immunity have been
long recognized64–66, and correspond well to the genetic
variation-associated disparity in human immune responses67.
Therefore, it is plausible to speculate that a large part of the
controversial arguments surrounding functions of certain
immune cells in cancer could arise because of host mice that
differ in immune system integrity, or genetic background.
Our work pinpointed ROS as an indispensable mechanism by
which neutrophils exert their dual roles in regulating both NK
cells and tumor cells. ROS are signaling molecules that play a
central role in host defense against invading pathogens and the
progression of inflammatory responses54. At infection or wound
sites, neutrophils are a key cell population producing a large
amount of ROS that not only function to eliminate the pathogens,
but also lead to endothelial dysfunction and tissue injury54. Thus,
ROS is a double-edged sword to the host in infectious and
inflammatory diseases. Similarly, the pro-tumoral and anit-
tumoral effects of ROS have also been repeatedly revealed in
cancer51. At low concentration levels, ROS can serve as second
messengers for a variety of signaling pathways such as phos-
phoinositide-3-kinase/Akt cascade, the mitogen-activated protein
kinase/Erk cascade, and the nuclear factor κ-B signaling pathway,
all of which are critical for tumor cell survival, proliferation,
differentiation and metabolism51. On the other hand, high con-
centrations of ROS are toxic to both tumor cells and the host
cells, especially the anti-tumor immune cells, leading to tumor-
icidal and immunosuppressive effects22,24. It is therefore not
surprising that ROS blockade showed both inhibitory and sti-
mulatory effects on cancer progression in mouse models68–70.
Our study indicated that neutrophil-derived ROS were able to act
on both host NK cells and tumor cells ex vivo (Fig. 5a–f), and
consequently showed both pro-metastatic and anti-metastatic
effects in vivo (Fig. 6f–i). The host immune system integrity,
particularly the NK cell status, was therefore critical to the ulti-
mate function of ROS in determining tumor-regulation in mice.
Again, taken together our results suggest a systemic evaluation of
a patient’s immune status will allow for a more precise and effi-
cacious use of ROS-targeting therapeutics in treating cancer. In
our future work, it will also be a fascinating and important
research direction to further investigate the influence of
neutrophil-derived ROS on distinct lung resident cell subsets
during breast cancer progression, as well as in other inflammatory
diseases. The results will help us to develop a deeper and more
precise understanding of the lung biology in steady and patho-
logical conditions.
Methods
Mice. C57BL/6J (JAX stock #000664), BALB/c (JAX stock #000651), NOD.Cg-
Prkdcscid/J (NOD-scid, JAX stock #001303), B6.Cg-Prkdcscid/SzJ (B6-scid, JAX stock
#001913) and NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG, JAX stock #005557) mice
were obtained from the Jackson Laboratory. The mice were fed on a chow diet ad
libitum and housed in a specific pathogen-free facility in plastic cages at 22 °C and
40–50% humidity, with a daylight cycle from 6 a.m. to 6 p.m. The animal protocols
for the experiments described in this manuscript were approved by the Institu-
tional Animal Care and Use Committee of The Jackson Laboratory. The mice were
matched for age and sex in each experiment.
Tumor models. For orthotopic tumor transplantation models, tumor cells (5 × 105
cells) were re-suspended in 50 µl growth factor-reduced Matrigel (Corning) and
transplanted within the fourth mammary fat pads on the left flank of the recipient
mice. For experimental metastasis models, tumor cells (5 × 105 cells per injection)
were re-suspended in 100 µl PBS and infused into the recipient mice by tail vein
injection.
Cell culture. AT3 and 4T1 cells were maintained in DMEM supplemented with
10% fetal bovine serum (FBS). E0771 and YAC-1 cells were maintained in RPMI
1640 medium supplemented with 10% FBS. All cells were cultured in a 5% CO2
humidified incubator at 37 °C.
E0771-Luc, AT3-Luc and 4T1-Luc cells were derived from their parental cells
after infection with luciferase-expressed lentivirus vectors (addgene #17477).
Construct-positive cells were selected with puromycin. To overexpress G-csf, E0771
or AT3 cells were infected with the lentiviral vectors expressing the G-CSF protein
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coding DNA (gift from Dr. Robert A. Weinberg, Massachusetts Institute of
Technology).
Isolation of neutrophils and NK cells. Lung tissues were dissociated and digested
with 1.5 mg ml−1 collagenase (Sigma, St. Louis, MO) for 1 h at 37 °C. Red blood
cells were then lysed by ACK lysis buffer (Gibco, Gaithersburg, MD). Neutrophils
were purified using anti-Ly6G magnetic beads (Miltenyi Biotech, Auburn, CA)
according to the manufacturer’s instructions. NK cells were purified from spleen
cells using NK cell isolation kit (Miltenyi Biotech, Auburn, CA) or from lung
dissociated cells using the CD49b (DX5) MicroBeads (Miltenyi Biotech, Auburn,
CA). The purities for isolated neutrophils and NK cells were above 95% and 90%,
respectively, as analyzed by flow cytometry.
Bioluminescence imaging. Bioluminescence imaging (BLI) of the luciferase
activity in tumor cells was used to monitor the tumor metastasis progression with
a Xenogen IVIS system. Before performing the BLI, the mice were anesthetized
under 2.5% isoflurane and administered with D-luciferin (150 mg kg−1; Gold
Biotechnology, St. Louis, MO) by intraperitoneal (i.p.) injection 10 min before the
imaging. At the end time point, the lungs were harvested in a 24-well plate in
150 μg ml−1 D-luciferin diluted in PBS for bioluminescence imaging. Image
exposure times were between 10 s and 1 min, depending on the signal strength.
Light emission from the region of interest was quantified as photons s−1 cm −2
steradian−1.
Neutrophil depletion and G-CSF treatment. For neutrophil depletion studies, the
mice were administrated with control IgG or anti-Ly6G (Clone 1A8; Bio X Cell,
West Lebanon, NH) at a dose of 12.5 µg per mouse per day for 10 consecutive days.
For in vivo G-CSF administration, recombinant mouse G-CSF (Pepro tech,
Rocky Hill, NJ) was i.p. injected daily at the dose of 2.5 μg per mouse.
NK cell depletion. To deplete NK cells in NOD-scid mice, anti-asialo GM1
(Biolegend #146002) was i.p. injected to the recipient mice at a dose of 25 μl per
mouse every 3 days. To deplete NK cells in B6-scid mice, anti-NK1.1 antibody (Bio
X cell # BE0036) was given to the recipient mice at a dose of 25 μg per mouse by i.p.
injection every 3 days.
ROS measurement. Once the mice were euthanized, their lungs were dissected, put
in a 24-well plate with 1 ml PBS and kept in an incubator for 10mins at 37 °C. Then
2 μl L-012 (Sigma # SML2236, 5 mgml−1 in H2O) was added to each well and the
bioluminescence images were captured with a Xenogen IVIS system. Light emission
from the region of interest was quantified as photons s−1 cm−2 steradian−1.
Flow cytometry. For NK cell surface marker analysis, cells were suspended in
staining buffer (PBS, 2% FBS) at a concentration <2 × 107 cells ml−1 and 100 μl of
suspension was incubated with fluorochrome-conjugated CD45, CD3e, CD49b,
NKp46, Ly6G, and CD107a antibodies (Biolegend, San Diego, CA) for 30 min on
ice. The dilution for antibodies used in flow cytometric analysis is 1:200. Cells were
washed twice with staining buffer. Fluorescence intensity was measured by flow
cytometry (FACSymphony A5, BD Immunocytometry, San Jose, CA). For detec-
tion of intracellular IFNγ, cells were primed with PMA (100 ng ml−1) and iono-
mycin (1 μg ml−1) for 4 h. Then the cells were fixed after surface staining,
permeabilized with Cytofix/Cytoperm (BD Biosciences, San Jose, CA) and stained
with an anti-IFNγ antibody (Biolegend, San Diego, CA). Data were analyzed using
FlowJo software.
NK cell and neutrophil co-culture. NK cells (4 × 105 cells) derived from spleens of
NOD-scid mice were premixed with or without isolated neutrophils at a ratio of 1:1
for 2 h, and the cell mixture was then added to luciferase-labeled AT3 cells or
stained YAC-1 cells at the NK cell: target ratios of 5:1, 10:1 or 20:1 for tumoricidal
assay. To determine the mechanisms underlying neutrophil-mediated NK cell
suppression, ROS inhibitors HDC (300 μg ml−1), apocynin (100 μM) or catalase
(1000 Uml−1), or NO synthase inhibitor 1400W dihydrochloride (10 μg ml−1)
was added when NK cells were premixed with neutrophils.
Neutrophil conditioned medium. Neutrophils were freshly isolated from lungs of
E0771-g-csf-bearing NOD-scid mice, and were primed with PMA (100 ng ml−1) for
1 h. Then 3 × 106 cells were re-suspended in 3 ml RPMI 1640 medium and incu-
bated overnight. Finally, the supernatant was collected and mixed with an equal
volume of RPMI 1640 complete medium as the neutrophil conditioned medium
(CM). To determine the effects of neutrophil CM to kill tumor cells and suppress
NK cells, 1 ml neutrophil CM was added to 3 × 104 AT3 cells or 6 × 105 NK cells
for further tests.
Tumoricidal assay. For the cytotoxicity assay, purified NK cells, neutrophils or the
premixed NK cells and neutrophils were added to luciferase-labeled AT3 cells (3 ×
104 cells) at the effector: target ratios of 5:1, 10:1 or 20:1. They were incubated in 1
ml complete RPMI 1640 medium in a 24-well-plate for 20 h. The luminescence was
then detected by luminometer in a SpectraMax® microplate reader (Molecular
Devices, San Jose, CA). The tumor cell killing was calculated by the following
formula: cell killing (%)= (1-[luminescence of target cells with effector cells]/
[luminescence of target cells only]) × 100%. Alternatively, YAC-1 cells (1 × 104
cells) were first stained with CellTrace CFSE (Thermo Fisher Scientific, Waltham,
MA), and were then incubated with effector cells at effector: target ratios of 1:1, 5:1,
10:1 or 20:1 in 1 ml complete RPMI 1640 medium in a 24-well-plate for 4 h. The
percentages of YAC-1 cell killing were analyzed by flow cytometry. All data shown
are the mean ± SD of four biologically independent cell cultures.
Statistics and reproducibility. The Prism software (version 7.04, GraphPad
Software Inc.) was used for all statistical analyses. All data represent mean ± SEM
or mean ± SD as indicated. The details of the statistical tests carried out are indi-
cated in the respective figure legends. Values were compared using either an
unpaired two-tailed t-test to compare two groups or ordinary one-way ANOVA
with Tukey’s multiple comparisons test to compare the variance in three or more
groups with one independent factor (e.g. treatment group). We employed two-way
ANOVA when there were effects of two factors (e.g. treatment and time) on a
dependent variable. P value smaller than 0.05 was considered significant, whereas
greater than 0.05 was assigned as not significant (ns). Exact p values are provided in
each figure. Two (indicated in figure legends of Supplementary Figs. 3, 6, 7, 10, and
11) or three independent experiments (all other figures and supplementary figures)
were performed and similar results were obtained.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1b–d, f, g, 2b, d–g, i, j, 3c, e–i, 4b–d, f–h, j, k, 5b–f, 6b–e,
g, i and Supplementary Figs. 1b, c, e, 2a, b, 4a–i, 5b–d, 6b, 8a, b, d–f, h–j, 9b, c, 10b, c,
11a–c are provided as a Source Data file. All the other data supporting the findings of this
study are available within the article and its supplementary information files and from
the corresponding author upon reasonable request. Source data are provided with
this paper.
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